Deerfield Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,255
| Closed | -$153K | – | 262 |
|
|
2024
Q3 | $153K | Buy |
13,255
+2,414
| +22% | +$28K | ﹤0.01% | 430 |
|
|
2024
Q2 | $128K | Sell |
10,841
-4,512
| -29% | -$53.2K | ﹤0.01% | 421 |
|
|
2024
Q1 | $182K | Buy |
+15,353
| New | +$182K | ﹤0.01% | 340 |
|
|
2022
Q2 | – | Sell |
-830,472
| Closed | -$12.2M | – | 130 |
|
|
2022
Q1 | $12.2M | Sell |
830,472
-344,659
| -29% | -$5.08M | 0.27% | 65 |
|
|
2021
Q4 | $15.5M | Sell |
1,175,131
-988,423
| -46% | -$13.1M | 0.33% | 68 |
|
|
2021
Q3 | $37.8M | Hold |
2,163,554
| – | – | 0.74% | 40 |
|
|
2021
Q2 | $51.8M | Buy |
2,163,554
+1,143,549
| +112% | +$27.4M | 0.92% | 33 |
|
|
2021
Q1 | $26.2M | Buy |
+1,020,005
| New | +$26.2M | 0.55% | 62 |
|
|
2019
Q4 | – | Sell |
-890,668
| Closed | -$10.3M | – | 88 |
|
|
2019
Q3 | $10.3M | Sell |
890,668
-327,000
| -27% | -$3.79M | 0.42% | 59 |
|
|
2019
Q2 | $27M | Buy |
1,217,668
+567,668
| +87% | +$12.6M | 0.97% | 35 |
|
|
2019
Q1 | $18.6M | Hold |
650,000
| – | – | 0.71% | 44 |
|
|
2018
Q4 | $12.8M | Hold |
650,000
| – | – | 0.51% | 53 |
|
|
2018
Q3 | $14.4M | Buy |
+650,000
| New | +$14.4M | 0.51% | 59 |
|